NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/11/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,595.01 mln
Float13.30 mln
Earnings Date09/11/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.72
Likely reliable
1-Year Forecast
89.62
Transformational upside
Relative Strength
24
/ 100
Significantly lagging
Debt / Equity
1.07
Elevated leverage
Pre-Tax Margin
-11%
Loss-making
Business Description
AnaptysBio Inc. is a San Diego-based biotechnology company working to develop treatments for autoimmune and inflammatory conditions. Its pipeline includes several promising drug candidates at various stages of clinical testing, targeting diseases such as rheumatoid arthritis, psoriasis, celiac disease, and certain cancers. The company works alongside partners GSK and Vanda to advance its research programs from early discovery through clinical development.
